Dividends Inside 
Danaher Corporation
DHR
$197.93 (+ $4.21 + 2.17%)
Last updated: 2026-07-03 21:37 UTC
Danaher Corporation trades under ticker DHR on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US2358511028, CUSIP 235851102.
About the Company
Danaher Corporation is a leading science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. It operates primarily through three key segments: Biotechnology, which provides tools and services for bioprocessing, genomics, and proteomics; Life Sciences, offering advanced instrumentation for research in microscopy, flow cytometry, and mass spectrometry; and Diagnostics, delivering clinical instruments, software, and consumables for laboratory diagnostics, pathology, and healthcare settings. Danaher Corporation's portfolio includes diagnostic equipment, digital imaging systems, optical instruments, microscopes, water quality control systems, and disinfection solutions, serving healthcare providers, research institutions, pharmaceutical companies, and industrial clients. These offerings support critical applications in drug discovery, disease diagnosis, environmental monitoring, and quality assurance across global markets. Founded in 1984 and headquartered in Washington, District of Columbia, Danaher Corporation plays a vital role in advancing scientific innovation and improving health outcomes through its integrated solutions.
Price History
Latest News for DHR
Here Are Friday’s Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, and More
Pre-Market Stock Futures: Futures are trading sharply lower as we get set to end one of the most exciting weeks on Wall Street in 25 years. Positive meetings in China with President Trump, who brought his CEO contingent and Elon Musk, and President Xi, massive upside earnings and forward guidance from an OG tech and ... Here Are Friday’s Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, a
10 Quality Stocks That Hit New Lows This Week—and Look Like Bargains
Even as tech surges, many other sectors in the market are trading at surprisingly attractive prices.
Jim Cramer Discusses the Performance of Danaher and Its Peers
Danaher Corporation (NYSE:DHR) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer called it a “one-time excellent company,” as he said: For instance, Danaher, another one-time excellent company, has seen the stock just get pulverized after not-so-great quarters, or I […]
Is Danaher Corporation (DHR) A Good Stock To Buy Now?
Is DHR a good stock to buy? We came across a bullish thesis on Danaher Corporation on r/ValueInvesting by One_Complaint_2945. In this article, we will summarize the bulls’ thesis on DHR. Danaher Corporation’s share was trading at $174.04 as of May 4th. DHR’s trailing and forward P/E were 33.94 and 20.66 respectively according to Yahoo Finance. Danaher […]
Danaher Digital Transformation Strategy Analysis Report 2026: Technology Focus and Initiatives, Partnerships and Acquisitions, ICT Budget & Contracts, Tech Ecosystem
Danaher Corp leverages technology and digital transformation in life sciences, diagnostics, and biotechnology. Opportunities lie in innovation initiatives, strategic partnerships, and acquisitions to advance diagnostics and biological medicine production, emphasizing DNA, RNA, and protein research.Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Danaher Corp. - 2026" company profile has been added to ResearchAndMarkets.com's offering. The report provides detailed i
Is Danaher (DHR) Pricing Look Interesting After Recent Life Sciences Portfolio Focus News
If you are wondering whether Danaher's current share price reflects its underlying worth, the recent performance gives plenty to think about. The stock closed at US$175.66, with returns of a 1.8% decline over 7 days, 8.0% decline over 30 days, 23.8% decline year to date, 9.2% decline over 1 year, 12.7% decline over 3 years, and 19.7% decline over 5 years. Recent news around Danaher includes ongoing attention on its portfolio positioning and market role in life sciences tools, which can shape...